Cadence and Perrigo settle patent dispute

San Diego-based Cadence Pharmaceuticals Inc. (Nasdaq: CADX) said Wednesday that it settled a patent dispute with Perrigo Co. (Nasdaq: PRGO) on its only marketed drug, the fever and pain treatment Ofirmev.